MedPath

Gagnon, David J

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)

Phase 2
Terminated
Conditions
Out-Of-Hospital Cardiac Arrest
Pneumonia
Interventions
Drug: Standard of care without prophylaxis
Drug: Antibiotic prophylaxis
First Posted Date
2021-08-11
Last Posted Date
2025-04-17
Lead Sponsor
David J. Gagnon
Target Recruit Count
53
Registration Number
NCT04999592
Locations
🇺🇸

Maine Medical Center, Portland, Maine, United States

© Copyright 2025. All Rights Reserved by MedPath